The available human studies do not indicate that an isoflavone exposure as reported in the thoroughly studied Asian population or as investigated in clinical studies (i.e., about 100 mg/day) negatively influences breast cancer risk or the thyroid hormone system in healthy women. This evidence concerns the gene TG and breast carcinoma.